Home / Learn / Precision Medicine / Treatment / Immunotherapy / Immune-Related Adverse Events

Immune-Related Adverse Events

The Latest Resources

Members of the ACCC IO Institute Executive Committee discuss the importance of standardizing education for Immunotherapy patients and how designating a champion within your practice can play a critical role in the success of irAE identification and management.(features Sanjiv Agarwala, MD; and Niesha Griffith, MS, RPH, FASHP)

irAE Workup Guidelines

Many organizations have published formal recommendations, or workup guidelines, for managing irAEs, including ASCO, ESMO, NCCN, and SITC.The following can be used as a directory for the current irAE workup guidelines.
Subspecialty Insights in Immuno-Oncology: A Closer Look at APPs
By Sarah Sagorsky, MPAS, PA-C

Advanced Practice Providers (APPs), such as nurse practitioners and physician assistants, play a fundamental role within medical oncology departments and the care of patients with cancer.
Managing Dermatologic Adverse Events From Immunotherapy
By Joshua Arbesman, MD

Oncodermatology is a rapidly developing field that is attracting significant interest and generating new literature in the context of cancer treatment strategies.
Emergency Medicine Providers: Key Partners in the Acute Care of irAEs
By Jason Bischof, MD

The non-specific adverse events of immune-based therapies, which often mimic autoimmune disorders rather than traditional cytotoxic effects, pose a significant challenge to emergency medicine providers.

View & Filter All IO Resources

From Oncology Issues

Collaborative Learning Workshops Explore Best Practices for Implementing Cancer Immunotherapies in the Community
Elevating Survivorship: Results from Two National Surveys

In order to explore experiences and needs concerning cancer survivorship from both the provider and the patient perspectives, ACCC and NCCS partnered to field two online surveys to oncology providers and cancer survivors, respectively.
A Physician Champion Takes a Practice-Based Immunotherapy Program to the Next Level
Tracy Virgilio, RN, MSN, OCN

Early symptom management is key to improving quality of life for patients with cancer, and proactive monitoring delivers unparalleled survival advantage while decreasing emergency visits and admissions. However, immunotherapies require special attention and procedures. Sidney Kimmel Cancer Center earned a 2018 ACCC Innovator Award for their immunotherapy triage algorithms, which provide non-oncology physicians and nurses with the tools to manage IO patients and prevent unnecessary admissions.

Blog Posts

FROM THE ACCCBUZZ BLOG

Early Identification and Management of Pneumonitis and Other irAEs in Patients with NSCLC
By Sarah Sagorsky, MPAS, PA-C
September 01, 2023
As immune checkpoint inhibitors have become the standard of care for eligible patients with NSCLC, frequent monitoring of irAEs as well as provider and patient education on the signs and symptoms of pneumonitis can ensure improved clinical outcomes for patients.
A New Decade for Advancements in Immunotherapy
June 08, 2023
June is Cancer Immunotherapy Month, and ACCC is highlighting the important work that it and its partners are doing to increase patient access to these novel therapies.
June Is Cancer Immunotherapy Month
June 25, 2020
In recognition of Cancer Immunotherapy Month, ACCCBuzz talked to Sigrun Hallmeyer, MD, the chair of the ACCC Immuno-Oncology Institute’s Executive Committee.
Immunotherapy Clinical Trials During COVID-19
April 23, 2020

On-Demand Webinars

The Microbiome in Cancer Immunotherapy

Learn how the microbiome could potentially be used to predict and enhance response to I-O therapy and to recognize patients who could be at risk for developing immune-related adverse events.

Share